Legal and professional services group Gateley has acquired patent and trademark attorneys Adamson Jones. Adamson Jones is the eleventh business Gateley has acquired since its IPO in June 2015 and is the Group’s first Business Services Platform acquisition. Business Services is one of Gateley’s four Platforms, the...
Adamson Jones firm of IP specialists remains committed to expanding our capabilities throughout all areas of the business. East Midlands based patent attorney and trade mark attorney firm, Adamson Jones IP Ltd would like to introduce four members of the team that have joined us in...
BioAscent is forecasting another year of significant growth, projecting revenue of £6.8m/€9.1m in 2021. This third consecutive year of high double-digit growth reflects the company's increasing reputation for providing science-led and cost-effective integrated drug discovery services to the global biopharmaceutical industry. Since establishing its integrated drug...
Nottingham-based business founder Dr Shailendra Singh has been named as Small Business Entrepreneur of the Year for the Midlands winner at the Great British Entrepreneur Awards. In partnership with Starling Bank, the ceremony was held at Grosvenor House in London on 22 November and saw 159...
OCTOBER 2021 This Innovate UK SMART Grant is a fantastic opportunity for Myconeos, allowing us to apply our ground breaking asexual fungal breeding technology to achieve sexual breeding of P. camemberti strains and associated IP surrounding our second generation of novel Penicillium strains for the cheese...
The national Medilink UK Healthcare Business Awards 2021 shortlist has been revealed, with some of the most innovative life sciences organisations in UK making the final list. The awards look back over the last 12 months and provide a platform for life science organisations to...
Glasgow, UK, 21 September 2021 – Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the appointment of Joshua T. Brumm as its new Independent Chairman, succeeding Satish Jindal. Amphista’s CEO Dr Nicola Thompson said, “On behalf of the Amphista team I...
DevelRx, a company based in BioCity Nottingham, is delighted to announce a new partnership with Scitegrity (Discovery Park, Kent). DevelRx is an internationally recognised consultancy business founded in 2020 that provides expert support on CNS (central nervous system) drug discovery and development to all sectors of the...
Cambridge, UK – 14 September 2021 – Cresset Discovery Services, provider of contract research services for early phase of drug discovery, has announced it will collaborate with the University of Newcastle, Australia, to focus on drug reprofiling against oncology targets. The work will build on...
Nottingham based contract research organisation (CRO) Cellomatics Biosciences has reported year-on-year organic revenue growth of 30 percent since its inception in 2015, as demand for its bespoke preclinical and early discovery phase laboratory services and expertise continues to soar. Based at BioCity Nottingham, Cellomatics is a...